A case of Epstein-Barr virus-negative human immunodeficiency virus-related primary effusion lymphoma
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved..
Primary effusion lymphoma (PEL) is a rare subtype of large B-cell lymphoma associated with human herpesvirus-8. Most cases are co-infected with Epstein-Barr virus (EBV). The prognosis of PEL is extremely poor and no optimal treatment regimen has been established. We report a case of EBV-negative PEL in a 49-year-old human immunodeficiency virus-positive man, presenting with massive bilateral pleural effusion.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 24(2018), 6 vom: 23. Juni, Seite 487-491 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ota, Shinichiro [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.10.2018 Date Revised 01.10.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jiac.2018.01.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM281131643 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM281131643 | ||
003 | DE-627 | ||
005 | 20231225030927.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jiac.2018.01.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n0937.xml |
035 | |a (DE-627)NLM281131643 | ||
035 | |a (NLM)29454632 | ||
035 | |a (PII)S1341-321X(18)30028-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ota, Shinichiro |e verfasserin |4 aut | |
245 | 1 | 2 | |a A case of Epstein-Barr virus-negative human immunodeficiency virus-related primary effusion lymphoma |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.10.2018 | ||
500 | |a Date Revised 01.10.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a Primary effusion lymphoma (PEL) is a rare subtype of large B-cell lymphoma associated with human herpesvirus-8. Most cases are co-infected with Epstein-Barr virus (EBV). The prognosis of PEL is extremely poor and no optimal treatment regimen has been established. We report a case of EBV-negative PEL in a 49-year-old human immunodeficiency virus-positive man, presenting with massive bilateral pleural effusion | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Epstein–Barr virus (EBV) | |
650 | 4 | |a Human herpesvirus 8 (HHV-8) | |
650 | 4 | |a Human immunodeficiency virus (HIV) | |
650 | 4 | |a Positron emission tomography (PET) | |
650 | 4 | |a Primary effusion lymphoma (PEL) | |
650 | 7 | |a Anti-Retroviral Agents |2 NLM | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a DNA, Viral |2 NLM | |
700 | 1 | |a Fujikura, Yuji |e verfasserin |4 aut | |
700 | 1 | |a Yamamoto, Takayuki |e verfasserin |4 aut | |
700 | 1 | |a Maki, Yohei |e verfasserin |4 aut | |
700 | 1 | |a Kurokawa, Atsushi |e verfasserin |4 aut | |
700 | 1 | |a Maeda, Takuya |e verfasserin |4 aut | |
700 | 1 | |a Kanoh, Soichiro |e verfasserin |4 aut | |
700 | 1 | |a Kawana, Akihiko |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |d 1996 |g 24(2018), 6 vom: 23. Juni, Seite 487-491 |w (DE-627)NLM095488073 |x 1437-7780 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2018 |g number:6 |g day:23 |g month:06 |g pages:487-491 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jiac.2018.01.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2018 |e 6 |b 23 |c 06 |h 487-491 |